ArticleIndian journal of psychiatry2026
Change in metabolic parameters in bipolar disorder: A retrospective-to-current evaluation design.
Article in Indian journal of psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: There is limited longitudinal data on prevalence of metabolic disturbances in patients with bipolar disorder (BD). Aim: To compare the prevalence of metabolic markers in patients with BD at two different times. Materials and Methods: The study participants were assessed at two time points and we used retrospective-to-current evaluation design. The International Diabetes Federation's Consensus Criteria were used to assess the metabolic syndrome (MetS) in seventy-four BD patients at baseline and at least a year following the baseline examination. Results: Participants had an average age of onset of 28.24 years and the mean age at the time of assessment at follow-up was 44.08 years. Most participants were men, from urban locality, married, and unemployed. Approximately one-third of the participants (37.8%) at the baseline assessment and 63.5% at the follow-up evaluation after about 4 years of baseline assessment met the MetS criteria. The most frequent metabolic abnormality was abnormal waist circumference (WC) at both assessments, and when compared to the baseline assessment, a follow-up assessment revealed a significant increase in weight, body mass index, WC, fasting blood glucose, HbA1C, triglycerides, very low-density lipoprotein (VLDL), and prevalence of diabetes mellitus. Diabetes mellitus was shown to have an annual incidence of 2.42%, and the same for hypertension was 5.05%, and and that for dyslipidemia was 4%. Conclusion: Over a 4-year follow-up, there has been a noticeable increase in the prevalence of metabolic parameters and MetS. All this demand careful observation and taking these things into account when selecting drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.